Breaking newsCOVID-19
COVID-19 Breaking News: Observational studies – prospective longitudinal cohort – May 2022
Our highlighted selection of Covid-related obeservational studies from the scientific press for May 2022
From 1 January 2026, the 24 Days, 24 Modules: eanCampus Challenge invites neurologists worldwide — EAN members and non-members alike — to access 24 high-quality neurology modules for free.
Latest Posts
-
-
Our highlighted selection of Covid-related meta-analyses and systemic reviews from the scientific press for May 2022 -
The overarching theme for EAN 2022 is ‘Getting Evidence into Practice’, which will be the subject of a range of workshops and symposia at the congress. -
Following the election of the EAN Board on 25 June, the new board will be looking for new officers to join the ranks of its committees and working groups. Here's your chance to play a part in the future of neurology in Europe! -
EAN NewsCOVID-19Eur J NeurolTop ArticlesEAN NeuroCOVID-19 Task Force position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders
The EAN NeuroCOVID-19 Task Force has published a position paper on COVID-19 vaccination hesitancy among people with chronic neurological disorders in the European Journal of Neurology. -
The May edition of our EANpages editors' selection of notable recent papers from the scientific press. -
Executive PageFeatured SliderExecutive Page: Join the EAN Panels and reinforce our scientific backbone! (Plus ENERGY update, and our first Science School)
EAN Scientific Committee Chair, Prof. Thomas Berger, calls for members to join EAN's Scientific & Coordinating Panels, and provides an update on recent scientific activities. -
Paper of the MonthFeatured SliderResearch Paper of the Month: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme
Our authors of the month evaluated an experimental treatment for human prion disease, based on a fully humanised monoclonal antibody (PRN100) addressed against the cellular prion protein (PrP). -
Paper of the MonthCOVID-19Featured SliderCovid-19 Paper of the month: Clinical outcomes of COVID-19 infection among patients with Alzheimer’s disease or mild cognitive impairment
Our authors of the month conducted this retrospective case-control study in order to investigate the association of AD with the risk of COVID-19 infection (adjusted for comorbidities and sociodemographic factors). -
Next in our series of interviews with presidents of National Neurological Societies, Prof. Jean-Philippe Azulay from the French Society of Neurology. -
TREAT AIE, the first European networking conference to provide guidelines and improve treatment of Autoimmune Encephalitis, takes place in Florence, Italy on 29-30 April (with online participation also available) -
Resident and Research FellowsEducation cornerMentor/mentee pairs matched in second round of EAN Mentorship Programme
It is with great pleasure that we can announce the Mentees who have enrolled in the second round of our EAN Mentorship Programme to be matched with a Mentor to support them over the course of one year. -
EAN NewsEAN-ESO Joint session on ‘The Vascular side of Neurodegeneration: a preclinical and clinical perspective’
The EAN Scientific Panel on Stroke is delighted to announce a joint session between EAN and ESO, which will take place at the ESOC 2022, 4-6 May, 2022. -
Registration is now open for the May EAN Webinar on ICH treatment – are we too slow? -
The European Academy of Neurology (EAN) is proposing a new study on the topic of sleep & wake disorders, inspired by the European Brain Council's Value of Treatment projects